Children may have experienced “excess” doubling up during COVID-19 pandemic

The FDA granted marketing authorization for the Sepsis ImmunoScore, an artificial intelligence (AI) software tool for rapid diagnosis and risk assessment of sepsis, Prenosis announced

Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the

Junshi has conducted more than 40 company-sponsored clinical studies of the therapy. Credit: PeopleImages.com – Yuri A/Shutterstock. Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences